HC Wainwright Analysts Reduce Earnings Estimates for ABEO

Abeona Therapeutics Inc (NASDAQ:ABEO – Free Report) – Analysts at HC Wainwright cut their Q1 2025 EPS estimates for Abeona Therapeutics in a note issued to investors on Monday, March 24th. HC Wainwright analyst R. Selvaraju now anticipates that the biopharmaceutical company will earn ($0.36) per share for the quarter, down from their prior estimate […]

Leave a Reply

Your email address will not be published.

Previous post Wedbush Weighs in on KB Home’s Q2 Earnings (NYSE:KBH)
Next post Q1 Earnings Estimate for Medpace Issued By Leerink Partnrs